← FDA DRUG APPROVALS

FDA ANDA · ANDA075374

DIFLORASONE DIACETATE

Sponsor: AVONDALE PHARMS

APPLICATION
ANDA075374
TYPE
ANDA
ORIGINAL APPROVAL
1999-04-27
LATEST ACTION
2019-11-14
ROUTE
TOPICAL
DOSAGE FORM
OINTMENT
MARKETING STATUS
Prescription

Products

DIFLORASONE DIACETATEPrescription
DIFLORASONE DIACETATE 0.05% · OINTMENT · TOPICAL

Approval history

2019-11-14Labeling · Supplement 11 · standardAP
2019-11-14Labeling · Supplement 12 · standardAP
2005-04-12Labeling · Supplement 5AP
2003-10-02Labeling · Supplement 4AP
2003-08-19Labeling · Supplement 1AP
1999-04-27OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →